Özlü, EminKaradağ, Ayşe SerapAkdeniz, NecmettinUzunçakmak, Tuğba KevserZemheri, EbruÖzkanlı, Şeyma2020-04-302020-04-3020191087-2108https://hdl.handle.net/20.500.12684/445PubMed ID: 31046913Interferon beta (IFNß) is a drug used successfully in the treatment of multiple sclerosis (MS). Although IFNß is a safe and well-tolerated drug, dermatological side effects are common. The most common dermatological adverse effect is a local reaction at the injection site. It may also cause inflammatory and immune-mediated dermatological side effects. However, morphea induced by IFNßlb injection is very rare. © 2019, Dermatology Online Journal. All rights reserved.eninfo:eu-repo/semantics/closedAccessInterferon beta; Morphea; Side effectsArticle254Q3